发明名称 N-HYDROXY-2-(ALKYL, ARYL OR HETEROARYL SULFANYL, SULFINYL OR SULFONYL)-3-SUBSTITUTED ALKYL, ARYL OR HETEROARYLAMIDES AS MATRIX METALLOPROTEINASE INHIBITORS
摘要 1. A compound according to formula I wherein: R<1> is alkyl of 1 to 18 carbon atoms, optionally substituted with one or two groups selected independently from R<5>; alkenyl of 3 to 18 carbon atoms having 1 to 3 double bonds, optionally substituted with one or two groups selected independently from R<5>; alkynyl of 3 to 18 carbon atoms having 1 to 3 triple bonds, optionally substituted with one or two groups selected independently from R<5>; aryl of 6 to 10 carbon atoms, optionally substituted with one or two groups selected independently from R<5>; cycloalkyl of 3 to 8 carbon atoms, optionally substituted with one or two groups selected independently from R<5>; saturated or unsaturated 5 to 10 membered mono- or bicyclic heterocycle containing one heteroatom selected from O, S or NR<7>, optionally substituted with one or two groups selected independently from R<5>; or heteroaryl-(CH2)0-6 wherein the heteroaryl group is 5 to 6 membered with one or two heteroatoms selected independently from O, S, and N and may be optionally substituted with one or two groups selected independently from R<5>; A is -S-, -SO- or SO2-; R<2> and R<3>, taken with the carbon atom to which they are attached, form a 5 to 7 membered heterocyclic ring containing O, S or N-R<7> optionally having one or two double bonds; R<4> is hydrogen, alkyl of 1 to 6 carbon atoms, optionally substituted with one or two groups selected independently from R<5>; alkenyl of 3 to 18 carbon toms having 1 to 3 double bonds, optionally substituted with one or two groups selected independently from R<5>; alkynyl of 3 to 18 carbon atoms having 1 to 3 triple bonds, optionally substituted with one or two groups selected independently from R<5>; phenyl or naphthyl optionally substituted with one or two groups selected independently from R<5>; C3 to C8 cycloalkyl or bicycloalkyl optionally substituted with one or two groups selected independently from R<5>; saturated or unsaturated 5 to 10 membered mono- or bicyclic heterocycle containing one heteroatom selected from O, S or NR<7>, optionally substituted with one or two groups selected independently from R<5>; R<5> is H, C7-C11 aroyl, C2-C6 alkanoyl, C1-C12 alkyl, C2-C12 alkenyl, C2-C12 alkynyl, F, Cl, Br, I, CN, CHO, C1-C6 alkoxy, aryloxy, heteroaryloxy, C3-C6 alkenyloxy, C3-C6 alkynyloxy, C1-C6 alkoxyaryl, C1-C6 alkoxyhereroaryl, C1-C6 -alkylamino-C1-C6 alkoxy, C1-C2-alkylenedioxy, aryloxy-C1-C6 alkylamine, C1-C12 perfluoroalkyl, S(O)n-C1-C6 alkyl, S(O)n-aryl where n is 0, 1 or 2; OCOO-C1-C6 alkyl, OCOOaryl, OCONR<6>, COOH, COO-C1-C6 alkyl, COOaryl, CONR<6>R<6>, CONHOH, NR<6>R<6>, SO2NR<6>R<6>, NR<6>SO2aryl, NR<6>CONR<6>R<6>, NHSO2CF3, SO2NH heteroaryl, SO2NHCOaryl, CONHSO2-C1-C6 alkyl, CONHSO2aryl, SO2NHCOaryl, CONHSO2-C1-C6 alkyl, CONHSO2 aryl, NH2, OH, aryl, heteroaryl, C3-C8 cycloalkyl; or saturated or unsaturated 5 to 10 membered mono- or bicyclic heterocycle containing one heteroatom selected from O, S or NR<7>, wherein C1-C6 alkyl is straight or branched, heteroaryl is a 5-10 membered mono-or bicyclic heteroaryl group having 1 to 3 heteroatoms selected independently from O, S or NR<7> and aryl is phenyl or naphthyl, optionally substituted by 1 or 2 groups independently selected from halogen, cyano, amino, nitro, C1-C6 alkyl, C1-C6 alkoxy, or hydroxy; R<6> is H, C1-C18 alkyl optionally substituted with OH; C3-C6 alkenyl, C3-C6 alkynyl, C1-C6 perfluoroalkyl, S(O)n-C1-C6 alkyl, S(O)n aryl, where n is 0, 1 or 2; or COheteroaryl, wherein heteroaryl is a 5-10 membered mono- or bicyclic heteroaryl group having 1 to 3 heteroatoms selected independently from O, S or NR<7> and aryl is phenyl or naphthyl, optionally substituted by 1 or 2 groups selected from halogen, cyano, amino, nitro, C1-C6 alkyl, C1-C6 alkoxy, or hydroxy; and R<7> is C7-C11 aroyl, C2-C6 alkanoyl, C1-C12 perfluoroalkyl, S(O)n-C1-C6 alkyl, S(O)n aryl, where n is 0, 1 or 2; COO-C1-C6-alkyl, COOaryl, CONHR<6>, CONR<6>R<6>, CONHOH, SO2NR<6>R<6>, SO2CF3, SO2NHheteroaryl, SO2NHCOaryl, CONHSO-C1-C6-alkyl, CONHSO2aryl, aryl, or heteroaryl, where aryl is phenyl or naphthyl, optionally substituted by 1 or 2 groups selected independently from halogen, cyano, amino, nitro, C1-C6 alkyl, C1-C6 alkoxy, or hydroxy; and heteroaryl is a 5-10 membered mono- or bicyclic heteroaryl group having 1 to 3 heteroatoms selected independently from O, S or N-C1-C6 alkyl; alkyl of 1 to 18 carbon atoms, optionally substituted with one or two groups selected independently from R<5>; alkenyl of 3 to 18 carbon atoms having from 1 to 3 double bonds, optionally substituted with one or two groups selected independently from R<5>; alkynyl of 3 to 18 carbon atoms having from 1 to 3 triple bonds, optionally substituted with one or two groups selected independently from R<5>; arylalkyl of 7 to 16 carbon atoms, wherein aryl is optionally substituted with one or two groups selected independently from R<5>; biphenylalkyl of 13 to 18 carbon atoms, wherein biphenyl is optionally substituted with one or two groups selected independently from R<5>; arylalkenyl of 8 to 16 carbon atoms, wherein aryl is optionally substituted with one or two groups selected independently from R<5>; cycloalkylalkyl or bicycloalkylalkyl of 4 to 12 carbon atoms, wherein the cycloalkyl or bicycloalkyl group is optionally substituted with one or two groups selected independently from R<5>; saturated or unsaturated mono- or bicyclic heterocycle containing one heteroatom selected from O, S or N-C1-C6 alkyl, optionally substituted with one or two groups selected independently from R5; or R<8>R<9>N-C1-C6-alkoxyaryl-C1-C6-alkyl where R<8> and R<9> are independently selected from C1-C6 alkyl or R<8> and R<9> together with the nitrogen forms a 5-7 membered saturated heterocyclic ring optionally containing an oxygen atom, wherein the aryl group is phenyl or naphthyl; or a pharmaceutically acceptable salt thereof. 2. A compound according to Claim 1 wherein: R<1> is alkyl of 1 to 18 carbon atoms, optionally substituted with one or two groups selected independently from R<5>; alkenyl of 3 to 18 carbon atoms having 1 to 3 double bonds, optionally substituted with one or two groups selected independently from R<5>; alkynyl of 3 to 18 carbon atoms having 1 to 3 triple bonds, optionally substituted with one or two groups selected independently from R<5>; aryl of 6 to 10 carbon atoms, optionally substituted with one to two groups selected independently from R<5>; cycloalkyl of 3 to 8 carbon atoms, optionally substituted with one or two groups selected independently from R<5>; saturated or unsaturated mono- or bicyclic heterocycle of from 5 to 10 members containing one heteroatom selected from O, S or NR<7>, optionally substituted with one or two groups selected independently from R<5>; or heteroaryl-(CH2)0-6 wherein the heteroaryl group is 5 to 6 membered with one or two heteroatoms selected independently from O, S, and N and may be optionally substituted with one or two groups selected independently from R5; A is -S-, -SO- or SO2-; R<2> and R<3>, taken with the carbon atom to which they are attached, form a 5 to 7 membered heterocyclic ring containing O, S or NR<7> optionally having one or two double bonds; R<4> is hydrogen, alkyl of 1 to 6 carbon atoms, optionally substituted with one or two groups selected independently from R<5>; alkenyl of 3 to 18 carbon atoms having 1 to 3 double bonds, optionally substituted with one or two groups selected independently from R<5>; alkynyl of 3 to 18 carbon atoms having 1 to 3 triple bonds, optionally substituted with one or two groups selected independently from R<5>; phenyl or naphthyl optionally substituted with one or two groups selected independently from R<5>; C3-C8 cycloalkyl or bicycloalkyl optionally substituted with one or two groups selected independently from R5; R<5> is H, F, Cl, Br, I, CN, CHO, C7-C11 aroyl, C2-C6 alkanoyl, C1-C12 alkyl, C2-C12 alkenyl, C2-C12 alkynyl, C1-C6 alkoxy, aryloxy, heteroaryloxy, C3-C6 alkenyloxy, C3-C6 alkynyloxy, C1-C6 alkoxyaryl, C1-C6 alkoxyheteroaryl, C1-C6-alkylamino-C1-C6 alkoxy, C1-C2-alkylenedioxy, aryloxy-C1-C6 alkylamine, C1-C12 perfluoroalkyl, S(O)n-C1-C6 alkyl, S(O)n-aryl where n is 0, 1 or 2; OCOO-C1-C6 alkyl, OCOOaryl, OCONR<6>, COOH, COO-C1-C6 alkyl, COOaryl, CONR<6>R<6>, CONHOH, NR<6>R<6>, SO2NR<6>R<6>, NR<6>SO2aryl, NR<6>CONR<6>R<6>, NHSO2CF3, SO2NHheteroaryl, SO2NHCOaryl, CONHSO2-C1-C6 alkyl, CONHSO2aryl, SO2NHCOaryl, CONHSO2-C1-C6 alkyl, CONHSO2aryl, NH2, OH, aryl, heteroaryl, C3-C8cycloalkyl; or saturated or unsaturated 5 to 10 membered mono- or bicyclic heterocycle containing one heteroatom selected from O, S or NR<7>; wherein heteroaryl is a 5-10 membered mono- or bicyclic heteroaryl group having 1 to 3 heteroatoms selected independently from O, S or NR<7> and aryl is phenyl or naphthyl, optionally substituted by 1 or 2 groups selected independently from halogen, cyano, amino, nitro, C1-C6 alkyl, C1-C6 alkoxy, or hydroxy; R<6> is H, C1-C18 alkyl optionally substituted with OH; C3-C6 alkenyl, C3-C6alkynyl, C1-C6 perfluoroalkyl, S(O)n alkyl or aryl where n is 0, 1, or 2; or COheteroaryl; wherein heteroaryl is a 5-10 membered mono- or bicyclic heteroaryl group having l to 3 heteroatoms selected independently from O, S or NR<7> and aryl is phenyl or naphthyl, optionally substituted by 1 or 2 groups selected from halogen, cyano, amino, nitro, C1-C6 alkyl, C1-C6 alkoxy, or hydroxy; and R<7> is C7-C11 aroyl, C2-C6 alkanoyl, C1-C12 perfluoroalkyl, S(O)n-alkyl, S(O)n-aryl where n is 0, 1 or 2; COO-alkyl, COOaryl, CONHR<6>, CONR<6>R<6>, CONHOH, SO2NR<6>R<6>, SO2CF3, SO2NHheteroaryl, SO2NHCOaryl, CONHSO2alkyl, CONHSO2aryl, aryl, or heteroaryl; wherein C1-C6 alkyl is straight or branched, heteroaryl is a 5-10 membered mono- or bicyclic heteroaryl group having 1 to 3 heteroatoms selected independently from O, S or NR<7> and aryl is phenyl or naphthyl, optionally substituted by 1 or 2 groups selected from halogen, cyano, amino, nitro, C1-C6 alkyl
申请公布号 EA001742(B1) 申请公布日期 2001.08.27
申请号 EA19990000769 申请日期 1998.02.17
申请人 AMERICAN CYANAMIDCOMPANY 发明人 VENKATESAN, ARANAPAKAM, MUDUMBAI;GROSY, GEORGE, THEODORE;DAVIS, JAMIE, MARIE;BAKER, JANNIE, LEA
分类号 C07D295/08;A61K31/16;A61K31/165;A61K31/341;A61K31/351;A61K31/381;A61K31/40;A61K31/4035;A61K31/41;A61K31/415;A61K31/4164;A61K31/4166;A61K31/4184;A61K31/423;A61K31/426;A61K31/428;A61K31/433;A61K31/4402;A61K31/4406;A61K31/4409;A61K31/4436;A61K31/445;A61K31/4453;A61K31/4535;A61K31/47;A61K31/495;A61K31/4965;A61K31/5375;A61K31/55;A61P1/02;A61P1/04;A61P1/14;A61P3/10;A61P9/02;A61P9/04;A61P17/02;A61P19/02;A61P19/08;A61P29/00;A61P31/18;A61P35/00;A61P35/04;A61P37/06;C07C317/40;C07C317/44;C07C317/46;C07C323/60;C07D207/12;C07D209/48;C07D211/54;C07D211/66;C07D213/30;C07D213/32;C07D213/54;C07D213/56;C07D213/70;C07D213/71;C07D213/74;C07D213/89;C07D215/12;C07D215/36;C07D215/38;C07D215/48;C07D231/18;C07D233/02;C07D233/54;C07D233/64;C07D233/76;C07D233/84;C07D235/28;C07D241/12;C07D257/04;C07D263/58;C07D277/20;C07D277/36;C07D277/70;C07D277/74;C07D277/76;C07D285/14;C07D295/092;C07D307/30;C07D307/38;C07D307/64;C07D309/12;C07D333/28;C07D333/34;C07D409/04 主分类号 C07D295/08
代理机构 代理人
主权项
地址
您可能感兴趣的专利